EEG for Schizophrenia
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are a healthy control subject or a case-match control non-ill subject, you should not have used daily antidepressants, mood stabilizers, or antipsychotic medications in the last 6 months, or benzodiazepines in the last 2 days.
What data supports the effectiveness of EEG treatment for schizophrenia?
Research shows that EEG can detect brain changes in schizophrenia, and these changes are stable over time, suggesting they are not just side effects of treatment. Additionally, EEG abnormalities have been linked to better functioning in some areas for patients consistently diagnosed with schizophrenia.12345
Is EEG generally safe for humans?
EEG (electroencephalography) is generally considered safe for humans, as it is a non-invasive method used to record brain activity. However, some studies have noted EEG abnormalities in patients taking certain medications like clozapine, which can also lead to seizures in a small percentage of cases. These findings are related to the medication rather than the EEG procedure itself.678910
How does EEG treatment for schizophrenia differ from other treatments?
EEG (electroencephalography) is unique for schizophrenia as it is a non-invasive and inexpensive method that helps to understand brain activity patterns in patients, unlike traditional drug treatments that focus on altering brain chemistry. EEG can identify specific brain wave abnormalities, which may help tailor more personalized treatment approaches.25111213
What is the purpose of this trial?
This study aims to identify novel markers of psychosis using electroencephalography (EEG).
Eligibility Criteria
This trial is for adults aged 18-65 with good English skills, visual acuity of at least 20/32, and diagnosed with Bipolar Disorder or Schizophrenia-Spectrum Disorders as per DSM-5. Excluded are those with significant head injuries, intellectual impairments, recent substance abuse or suicidal behavior, current manic states, certain neurological conditions or treatments like ECT within the last 8 weeks.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
EEG Assessment
Participants undergo electroencephalography (EEG) to identify novel markers of psychosis
Follow-up
Participants are monitored for safety and effectiveness after EEG assessment
Treatment Details
Interventions
- EEG
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Rochester
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator